Titan Biotech announces 1:4 bonus issue and Rs 0.50 dividend

Corporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹414.85

prior close

₹435.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+4.4% vs market

Specialty Chemicals peers, median of 102sector+0.6%+4.4% vs sector

On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 4.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.6+4.4+0.6+4.4

Next day

+5.6+1.3+4.3+0.5+5.0

+0.0+1.7-1.7+0.8-0.7

-2.6+2.2-4.9+1.1-3.7

+1.3+2.1-0.8+1.2+0.1

+5.3+1.9+3.5+1.1+4.2

+0.4-1.3+1.7-2.3+2.6

15d

-4.5+1.3-5.9+0.8-5.4

-7.5-0.8-6.7-2.2-5.3

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 102Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Biotech board approved a bonus issue in ratio 1:4 (1 share for every 4 held), subject to shareholder approval at AGM on September 29, 2026. About 1.03 crore bonus shares will be issued using free reserves and securities premium. Paid-up capital rises from Rs 8.26 crore to Rs 10.33 crore. Board also recommended a final dividend of Rs 0.50 per share with record date September 22. Authorized capital increased from Rs 10 crore to Rs 10.4 crore.

Likely market impact

Share count rises about 25 percent after bonus, likely lowers per-share price. Small dividend. Pending shareholder approval.